Skip to content

MONOCRYL MCP347HRecalls & reported problems

Ethicon, LLC · Antibacterial Violet Monofilament (Poliglecaprone 25), Absorbable Surgical Suture · Class 2 · Implant

All models of MONOCRYL (127)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 10705031046443), received between Apr 13, 2022 and May 28, 2026 — classified as 5 malfunctions.

The most frequently reported specific device problem is “Material Separation” (3 reports).

2 other recalls cover devices cleared under the same FDA submission (K050845, K201996); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 1 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 1 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 2 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Material Separation3
  • Break2

Patient problems

  • No Clinical Signs, Symptoms or Conditions5

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 28, 2026Material Separation

    IT WAS REPORTED THAT A PATIENT UNDERWENT A LAP HYSTERECTOMY PROCEDURE ON AN UNKNOWN DATE AND SUTURE WAS USED. THE DOCTOR HAD PROBLEMS WITH THE SUTURE MATERIAL BREAKING AWAY FROM THE NEEDLE ITSELF. THIS OCCURRED IN BOTH LAP HYSTERECTOMIES TODAY. THE FIRST IN THE PATIENT AND REQUIRED SEARCHING FOR THE NEEDLE IN THE PATIENT CAVITY AND THE 2ND WHEN DR STRETCHED THE SUTURE BEFORE USE. THERE WERE NO PATIENT CONSEQUENCES REPORTED. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25317463 ↗
  • MalfunctionMay 27, 2026Material Separation

    IT WAS REPORTED THAT A PATIENT UNDERWENT A LAP HYSTERECTOMY PROCEDURE ON AN UNKNOWN DATE AND SUTURE WAS USED. THE DOCTOR HAD PROBLEMS WITH THE SUTURE MATERIAL BREAKING AWAY FROM THE NEEDLE ITSELF. THIS OCCURRED IN BOTH LAP HYSTERECTOMIES TODAY. THE FIRST IN THE PATIENT AND REQUIRED SEARCHING FOR THE NEEDLE IN THE PATIENT CAVITY AND THE 2ND WHEN DR STRETCHED THE SUTURE BEFORE USE. THERE WERE NO PATIENT CONSEQUENCES REPORTED. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25299207 ↗
  • MalfunctionFeb 12, 2026Material Separation

    IT WAS REPORTED THAT A PATIENT UNDERWENT AN UNKNOWN PROCEDURE IN (B)(6) 2026 AND SUTURE WAS USED. DURING THE PROCEDURE, THE DOCTOR WAS SUTURING THE MUSCLE FASCIA AND AT THE END OF IT THE NEEDLE CAME LOOSE FROM THE SUTURE, THE DOCTOR ARGUES THAT IT WAS A DEFECT IN THE SUTURE. NO ADVERSE PATIENT CONSEQUENCES WERE REPORTED. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24327723 ↗
  • MalfunctionApr 9, 2024Break; Break

    IT WAS REPORTED THAT A PATIENT UNDERWENT AN UNKNOWN PROCEDURE OF THE UTERUS ON AN UNKNOWN DATE; AND A SUTURE WAS USED. DURING THE PROCEDURE, THE NEEDLE BROKE DURING USE. THERE WERE NO ADVERSE CONSEQUENCES TO THE PATIENT. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19072579 ↗
  • MalfunctionApr 13, 2022Break; Break

    IT WAS REPORTED THAT A PATIENT UNDERWENT A C-SECTION PROCEDURE ON (B)(6) 2022 AND SUTURE WAS USED. SUTURE MATERIAL USED FOR THE CAESAREAN SECTION BROKE DURING THE PROCEDURE. THE NEEDLE BROKE AND SOME PART OF IT WAS LEFT INSIDE THE UTERUS BUT WAS RETRIEVED BEFORE CLOSING THE SHEATH. THE RADIOGRAPHER WAS NOT REQUIRED AS PER SURGEONS¿ INSTRUCTION BROKEN PARTS MEASURED TOGETHER FOR COMPLETENESS. THE PROCEDURE WAS DELAYED FOR AN UNSPECIFIED AMOUNT OF TIME, AND WAS SUCCESSFULLY COMPLETED. NO ADVERSE PATIENT CONSEQUENCES WERE REPORTED. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14106811 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K050845, K201996. One submission often covers many models, so check the product and lot details in each record.

  • Z-2149-2024 · May 10, 2024 · Open, Classified
    MONOCRYL Plus Antibacterial (poliglecaprone 25) Suture - Intended for use in general soft tissue approximation and/or ligation where an absorbable material is indicated. PRODUCT CO
  • Z-1312-2009 · Feb 2, 2009 · Terminated
    MONOCRYL Plus Antibacterial (poliglecaprone 25) Suture; Ethicon, Inc., A Johnson & Johnson Company, Somerville, NJ Sutures are intended for general soft tissue approximation and/o

Other SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID devices

All SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page